Puritan Wins 6 Year Battle To Correct Erroneous Copan Patent Title
GUILFORD, Maine, Nov. 15, 2018 /PRNewswire-PRWeb/ -- Puritan Medical Products Co., LLC, an American company with a worldwide reputation as a trusted manufacturer of swabs and single-use specimen collection devices, announced today that the United States Patent and Trademark Office recently granted its petition to correct the title of Copan's US Patent No. 8,114,027 B2.
Before correction, the title erroneously indicated that the patent was directed to a "Swab for Collecting Biological Specimens." In fact, the patent is not for a swab but is instead for a method. The corrected title, "Method for Collecting Biological Specimens," now reflects this.
About Puritan Puritan Medical Products Co., LLC, is an American company known worldwide as the trusted manufacturer of single-use products for the healthcare, diagnostic, forensic, critical environment, food safety, and drug manufacturing industries. Puritan manufactures all of its flocked swab products in their Guilford, ME, U.S. facility.
Expomed Eurasia, the most important medical exhibition between Europe and Asia, is ready to house more than a hundred companies, to discover new technological trends and the most innovative products which are going to change deeply the health market....
Nora Pharma, a Canadian pharmaceutical company, has received approval for its first Biosimilar product.
Nora Pharma, a wholly owned division of Sunshine Biopharma, has received approval from Health Canada for the commercialization of NIOPEG® (a...
PRESS RELEASE FOR IMMEDIATE PUBLICATION 19 April 2024 Dr. Sam Barrell CBE appointed as CEO of LifeArc LifeArc is pleased to announce the appointment of Dr. Sam Barrell, CBE, as Chief Executive Officer. Sam's appointment follows an extensive...
MasterControl, a leading provider of quality management and manufacturing execution software for life sciences, announced it has been recognized by the Imapac 2024 Asia-Pacific Biopharma Excellence Awards in the "Best Bioprocessing Supplier:...
Senstar Technologies Corporation , a leading international provider of comprehensive physical, video and access control security products and solutions, announced today that its Annual Report on Form 20-F for the year ended December 31, 2023 has been...
The report titled "Peptide Therapeutics Market by Technology (Hybrid Phase, Liquid Phase, Solid Phase), Drug Class (Adrenocorticotropic Hormone, Calcitonin, Insulin), Route of Administration, Application, End User, Manufacturing Type - Global...
